The workbook addresses several concepts and starts with the prevention of relapse. The major part of the workbook is how to develop support systems for maintaining recovery that contribute to successful recovery. The text shows many elements that contribute to addiction. It goes into detail about the genetic aspects of addiction. There is also a segment of how executive functioning of the brain can get impaired with addiction that compromises judgment, impulse control, and the ability to organize. But these impairments can be temporary with practicing having good judgment and impulse control, since new neuropathways can develop with exercising these functions. The stages of recovery and change are reviewed as well as the twelve steps of Alcoholics Anonymous and Narcotics Anonymous. One chapter is dedicated to powerlessness and unmanageability. At the end of each chapter, there are references for the reader to consult that have been used for the content of the workbook chapters. Find out more at https://www.amazon.com/Successful-Recovery-Relapse-Prevention-McCausland-ebook/dp/B079648R6X Non-fiction, self-help
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
This Is A Hip-Hop music video from the Battle 4 Seattle Movie Soundtrack Coming Everywhere Summer 2014 Watch This Explosive New Debut Music Video From This Hot Young Up-Incoming Hip-Hop Artist Davinchi Guaranteed To Blow You Away....He is has 218,000 Likes on Facebook, 90,000 Followers on Twitter...And is a # 1 Artist on Reverbnation He has over 700,000 fans world wide he call his Royal Family Crest.. He has just been accepted on Vevo.com and This music video is being reviewed by both BET & MTV networks.. Davinchi is becoming the most known hip-hop artist & actor on the planet!!! Like Davinchi at www.facebook.com/davinchiworldhiphop Follow him at www.twitter.com/davinchiworld Visit Him at www.davinchiworldhiphop.com Listen to his music at www.reverbnation.com/davinchiworld Instagram him at www.instagram.com/davinchiworldhiphop
In 2011, PetSafe® brand launched its nationwide Bark for Your Park program to help communities build their own off-leash dog parks. In order to help even more communities this year, PetSafe brand is restructuring the contest into a grant-giving program and increasing the number of awards from five to 25.
“In the past five years, we’ve given away over $850,000 to communities to build dog parks of their own, but now we want to help communities during every stage of development,” said Tracy Mulder, marketing manager, PetSafe brand. “Our new Bark for Your Park program is expanding to not only help break ground on new parks, but also help fund maintenance and improvements for existing parks.”
Communities can submit a grant application now through June 30, 2016 on www.petsafe.net/barkforyourpark. The applications will be reviewed by an internal committee and PetSafe brand will award five new park grants valuing $25,000 each, 10 park makeover grants valuing $10,000 each, and 10 park maintenance grants valuing $5,000 each. This year’s award recipients will receive a combination of funds and commercial-grade dog park equipment from UltraSite, a PlayCore Company. The winning communities will be announced over a 5-week period during August through September.
To view the multimedia release go to:
http://www.multivu.com/players/English/7827752-petsafe-dogs-bark-for-your-park/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Do science and religion conflict? Is there disagreement between science and spirituality? It turns out there is no conflict. The apparent conflict is because, till now, the metaphors of ancient texts such as the Bible, Talmud, and ancient Yoga Literature, had not been rigorously studied and compared to cutting edge scientific discoveries. Some of these studies have been reviewed by scientists and published in three international peer-reviewed scientific journals. Sanjay's research on the new agreements between spirituality and science is the first ever to get published in such high-ranking journals.
By Sanjay C. Patel, Author of GOD IS REAL - The Stunning New Convergence of Science and Spirituality. Visit: http://www.SanjayCPatel.com
Researchers at global public health organization NSF International, Harvard Medical School, the United States Department of Defense and the National Institute for Public Health and the Environment in the Netherlands (RIVM) recently identified four unapproved, DMAA-like stimulants in six over-the-counter weight-loss and pre-workout products currently available online. The research was published in the peer-reviewed journal Clinical Toxicology.
The potentially harmful compounds – including banned stimulants 1,3-DMAA and 1,3-DMBA as well as octodrine and a newly identified DMAA analog – were not listed as ingredients in the products and may have been disguised as “2-aminoisoheptane” or extract of Aconitum kusnezoffii. These stimulants may cause adverse cardiac events, hemorrhagic strokes or sudden death, especially if taken prior to strenuous exercise or combined with caffeine. Extreme heat and dehydration may also increase the health risks.
To view the multimedia release go to:
https://www.multivu.com/players/English/8216951-nsf-international-banned-stimulants-2-aminoisoheptane/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
https://www.therealtymedics.com ~ (321) 236-6690 Call Now!
All New homeowner clients - Hurry - Get Your July Only Discount! 2 months free of Central Florida & Orlando Property Management, or $250 Off.
The Realty Medics are experts in Orlando property management. If you’re renting out a home in Central Florida, The Realty Medics engineer the industry’s most advanced property management experience: You get the most out of your investment with the absolute least amount of hassle and inconvenience. With 1000+ homes under management, we’re the highest and most reviewed property manager on Yelp, Google, and the BBB.
Services: Property Management
Tenant Placement Service
Home Sales
Investor Home Sales
Construction and repair company
Sanjay\\\'s research has been reviewed favorably by internationally reputed scientists. Some of his research has even appeared in international, peer-reviewed scientific journals. Sanjay\\\'s research on the new agreements between spirituality and science is the first ever to get published in such high-ranking journals. This is the gold standard in scientific research and a landmark of superb research on the subject of science and religion or science and spirituality. Visit http://www.SanjayCPatel.com
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
